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Enterovirus D68 (EVD68) “belongs to the 
family Picornaviridae, genus Enterovirus, 
and species Human enterovirus D: (Kaida 
et al.,2011, para.2).  It is a small 
nonenveloped RNA virus (Xiang et al., 
2012).  EVD68 “shares characteristics 
with rhinoviruses, such as infection of the 
respiratory tract and acid lability” 
(Lauinger et al., 2012).   
Outbreaks 
EVD68 was first isolated in 1962 in 
California, where it was associated 
with bronchiolitis and pneumonia in 
children (Linsuwanon et al., 2012).  
EVD68 was rarely identified from 
1962-2007. Since 2008, several 
outbreaks of EVD68 have been 
identified.  The Philippines had an 
outbreak October 2008- March 
2009, Japan had an outbreak July- 
October 2010, and the Netherlands 
experienced an outbreak August- 
November 2010.  The United States 
has had three prior outbreaks: one 
in Georgia in September 2009, one 
in Pennsylvania also in September 
2009, and one in Arizona August- 
September 2010 (Imamura et al., 
2011). 
From mid-August to the present 
time, the USA has had 1116 
confirmed cases in 47 states as well 
as the District of Columbia 
(“Enterovirus D68 in the USA”).  
Most of the confirmed cases have 
been among children and EVD68  
“has been detected in specimens 
from 11 patients who died” 
(“Enterovirus D68 in the USA”). 
Testing 
Testing is not done on a routine 
basis.  Nasopharyngeal or 
oropharyngeal swabs are collected 
for testing.  In Ohio, testing must be 
approved by the Ohio Department 
of Health and specimens are sent to 
the CDC for testing (Enterovirus 
D68, 2014).  The CDC has developed 
a new test with just a few day 
turnaround for results (Enterovirus 
D68 in the USA). 
Pathophysiology 
Picture from “Enterovirus D68 in the USA” on CDC- activity of EVD68 
week of 10/26/2014-11/01/2014 
Several pathogenic viral 
mechanisms have been identified.  
They include virus implantation at 
the portal of entry, local replication, 
viral spread to target organs, and 
shedding of the virus into the 
environment (Baron, Fons, & 
Albrecht, 1996).  Viral affinity is 
determined by cell-receptors, “cell 
transcription factors that recognize 
viral promoters”, cell’s ability to 
support replication of the virus, as 
well as local temperature and pH 
(Baron et al., 1996, para. 3).  The 
primary site of infection of airway 
viruses is the epithelial cell of the 
airway (Jacoby, 2004).   
Airway epithelial cell infection  
“leads to functional changes that 
may initiate and orchestrate the 
early inflammatory and immune 
responses” (Jacoby, 2004, para. 2).  
The epithelial cells then “release a 
wide range of inflammatory 
cytokines: (Jacoby, 2004, para.2).  
Marked changes are noted in 
sensory nerve function, which may 
contribute to cough and 
bronchoconstriction.  Tachykinins in 
the lungs are increased and neutral 
endopeptidase activity is decreased 
leading to increased sensitivity to 
cough.  Vagally-mediated  
bronchoconstriction “is due to 
increased acetylcholine release as a 
result of inhibitory M2 muscarinic 
receptors on the cholinergic nerve 
fibers” (Jacoby, 2004, para. 5).  
“Endogenously-produced 
interferons can also increase 
vagally-mediated 
bronchoconstriction”  (Jacoby, 
2004, para. 8).  Eosinophils localize 
to airway nerves and also 
contribute to cough (Jacoby, 2004). 
Typical signs and symptoms include fever, 
runny nose, cough, sneezing, and body 
aches; while more severe symptoms include 
wheezing and dyspnea (“EVD68”, 2014).  
Clinical diagnosis consists of asthma 
exacerbations, pneumonia, and upper 
respiratory infections (Rahamat-Langendoen 
et al., 2011).  EVD68 has also been 
implicated in some neurologic symptoms: 
limb weakness or paralysis, “cranial nerve 
dysfunction and abnormalities” in gray 
matter of the spine (Wilson & Botelho, 2014, 
para. 12).  Asthmatics seem to be more 
severely affected by EVD68.    
Transmission 
EVD68 is spread by coming in contact 
with an infected person or their 
secretions, especially respiratory 
secretions (“What Families Need to 
Know”, 2014).  The virus can also live for 
some time on inanimate surfaces that 
have been contaminated with 
secretions (“Separating Fact from 
Fiction”, 2014).  
Treatment 
There is no specific treatment for EVD68.   
Since the infection is caused by a virus, 
antibiotics would be ineffective.  There are 
no antiviral medications currently available 
to treat EVD68 (Herold, 2014).  Treatment 
may include antipyretics, cough medicines, 
bronchodilators, oxygen, and mechanical 
ventilation if required.  
Preventing Spread of EVD68 
Prevention is key to decreasing the spread of EVD68.  Preventative techniques 
include good hand-washing, not sharing cups and eating utensils, covering 
coughs and sneezes, regular disinfection of frequently touched objects, and 
staying home when sick.  Avoid touching eyes, nose, and mouth.  
Educating Parents 
Because of all the media attention, may parents are terrified of this virus.  
Teach parents the importance of preventing the spread of all viruses, 
including EVD68, by the aforementioned strategies.  Encourage them to 
train their children.  Parents of asthmatics need to keep on top of their 
child’s asthma action plan.  Make sure their children are taking 
maintenance medications as prescribed and that they always have their 
rescue inhaler available.  Instruct parents to seek immediate treatment if 
their child is having trouble breathing or drinking, appears distressed, or 
exhibits other worrisome symptoms.  Remember, parents know their 
children better than we do.  
